751062
Last Update Posted: 2021-02-02
Recruiting has ended
All Genders accepted | 40 Years + |
267 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia
PhXA41 is not inferior to timolol in reducing intra-ocular pressure
Eligibility
Relevant conditions:
Open Angle Glaucoma
Ocular Hypertension
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov